Showing results (61-70 of 94) with videos related to
Sort By:
Pageof 10
Cancer Letters|December 8, 2020
A metabolic switch to memory CAR T cells: Implications for cancer treatmentHosein Rostamian, Keyvan Fallah-Mehrjardi, Mohammad Khakpoor-Koosheh, et al.Iranian Journal of Immunology : IJI|March 16, 2022
Identification of the Optimal Pattern of the Injection and Dosage of DC Immunotherapy Using the Mathematical Models Based on Ordinary Differential EquationsBahareh Zand, Samaneh Arab, Nasim Kheshtchin, et al.Journal of Cellular and Molecular Medicine|February 26, 2021
Dendritic cells loaded with exosomes derived from cancer stem cell-enriched spheroids as a potential immunotherapeutic optionMarzieh Naseri, Margot Zöller, Jamshid Hadjati, et al.Cancer Cell International|January 5, 2018
Study of the tumor microenvironment during breast cancer progressionRahil Eftekhari, Rezvan Esmaeili, Reza Mirzaei, et al.Frontiers in Immunology|September 28, 2020
Highly Efficient Generation of Transgenically Augmented CAR NK Cells Overexpressing CXCR4Arezoo Jamali, Jamshid Hadjati, Zahra Madjd, et al.Journal of Translational Medicine|November 28, 2021
CRISPR/Cas9-mediated TGFβRII disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells in vitroKhadijeh Alishah, Matthias Birtel, Elham Masoumi, et al.Cells|July 2, 2021
Chimeric Antigen Receptor (CAR) T Cell Therapy for Metastatic Melanoma: Challenges and Road AheadTahereh Soltantoyeh, Behnia Akbari, Amirali Karimi, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 27, 2012
Upregulation of CD200 is associated with Foxp3+ regulatory T cell expansion and disease progression in acute myeloid leukemiaAli Memarian, Maryam Nourizadeh, Farimah Masoumi, et al.Journal of Cellular Biochemistry|January 24, 2019
Construction of a chimeric antigen receptor bearing a nanobody against prostate a specific membrane antigen in prostate cancerMahmoud Hassani, Fatemeh Hajari Taheri, Zahra Sharifzadeh, et al.Immunology Letters|April 15, 2020
Pharmacological targeting of immune checkpoint A2aR improves function of anti-CD19 CAR T cells in vitroKeyvan Fallah-Mehrjardi, Hamid Reza Mirzaei, Elham Masoumi, et al.Pageof 10